Bill Harvey: Descending Belladonna

This week, we are running a feature from our friends at Cameron Optometry in Edinburgh. Having reached the point where they have 50 patients undergoing myopia management, they have reviewed their data so far and offer some useful hints for those of you looking to develop your myopia clinics. Refreshingly, they are as open about what has not worked as they are about their successes – something, I think you’ll agree, we could do with more of in clinical publications.

Like many of us interested in myopia, Ian Cameron states how he is looking forward to the publication of the Childhood Atropine for Myopia Progression (CHAMP) study, and feels that the use of atropine in myopia intervention is likely to become a major player in the coming years. The CHAMP study is investigating whether the use of low dose atropine (0.01%) eye drops can slow the progression of myopia in children compared to a placebo drop.